Boehringer Ingelheim Venture Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 14

Professionals

  • Investments
  • 106

  • Portfolio
  • 41

  • Exits
  • 23

Exits

Boehringer Ingelheim Venture Fund General Information

Company Description

Founded in 2010, Boehringer Ingelheim Venture Fund is a corporate venture capital arm of Boehringer Ingelheim based in Ingelheim am Rhein, Germany. The seeks prefers to invest in companies operating in digital health, immune-oncology, regenerative medicine, and other technology sectors.

Business Details

Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • Binger Straße 173
  • 55216 Ingelheim am Rhein
  • Germany

Boehringer Ingelheim Venture Fund Investments (106)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
EvlaBio 07-Jul-2025 Seed Round Biotechnology Generating Revenue
Nuevocor 06-May-2025 Biotechnology Pre-Clinical Trials
HepaRegenix 15-Apr-2025 Drug Discovery Generating Revenue
ArrePath 26-Mar-2025 Drug Discovery Generating Revenue
Brainomix 10-Mar-2025 Diagnostic Equipment Generating Revenue
Refoxy Pharma 04-Dec-2024 Drug Discovery Pre-Clinical Trials
Aignostics 29-Oct-2024 Decision/Risk Analysis Generating Revenue
Synthetica (China) 26-Jul-2024 Biotechnology Pre-Clinical Trials
glucura 17-Jul-2024 Later Stage VC Other Healthcare Technology Systems Generating Revenue
Tacalyx 11-Jun-2024 Seed Round Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 106 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim Venture Fund Exits (23)

Company Name Exit Date Exit Type Exit Size
TigaTx 07-Apr-2025 Merger/Acquisition
Dirico 06-Dec-2024
Cardior 25-Mar-2024
Metabomed 08-Feb-2024
Delonix Bioworks 31-Dec-2023
T3 Pharmaceuticals 22-Nov-2023
Aelin Therapeutics 07-Jul-2023
Anagenesis Biotechnologies 05-Dec-2022
OncoMyx Therapeutics 01-Jul-2022 Out of Business
Abexxa Biologics 21-Sep-2021 Merger/Acquisition
You’re viewing 10 of 23 exits. Get the full list »

Boehringer Ingelheim Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Boehringer Ingelheim Venture Fund Co-Investors (148)

Name With Exits Lead Partner Series Industry
High-Tech Gründerfonds 8 Series chart Industry bar
Kurma Partners Series chart Industry bar
Korea Investment Partners Series chart Industry bar
NRW.Bank Series chart Industry bar
Wellington Partners Series chart Industry bar
You’re viewing 5 of 148 co-investors. Get the full list »

Boehringer Ingelheim Venture Fund FAQs

  • What is Boehringer Ingelheim Venture Fund?

    Founded in 2010, Boehringer Ingelheim Venture Fund is a corporate venture capital arm of Boehringer Ingelheim based in Ingelheim am Rhein, Germany.

  • When was Boehringer Ingelheim Venture Fund founded?

    Boehringer Ingelheim Venture Fund was founded in 2010.

  • Where is Boehringer Ingelheim Venture Fund headquartered?

    Boehringer Ingelheim Venture Fund is headquartered in Ingelheim am Rhein, Germany.

  • What is Boehringer Ingelheim Venture Fund's total asset value?

    Boehringer Ingelheim Venture Fund has around in total assets under management.

  • How many investments has Boehringer Ingelheim Venture Fund made?

    Boehringer Ingelheim Venture Fund has made 106 investments.

  • What has Boehringer Ingelheim Venture Fund invested in?

    Boehringer Ingelheim Venture Fund has made numerous investments in companies like EvlaBio, Nuevocor, and HepaRegenix within the Biotechnology and Drug Discovery industries.

  • What has Boehringer Ingelheim Venture Fund invested in recently?

    Boehringer Ingelheim Venture Fund's latest investment was on 07-Jul-2025 in EvlaBio, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »